img

Global Vector-Based RNAi Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vector-Based RNAi Market Research Report 2024

Vector-based RNAi (RNA interference) offers a system of treatment and disease management to decrease the inhibition of gene translation or expression, as well as it neutralizes the targeted mRNA molecules. Vector-based RNAi plays very important in cancer treatment,cancer is the top second cause of death across the globe. As well as a new development in vector-based RNAi such as small interfering RNAs (siRNA) and microRNAs (miRNA) can escalate the vector-based RNAi market growth. The challenging situation of FDA approval affecting on a number of new drugs launch, for instance, 2015 (41 drugs), while in 2016 (19 drugs) which are very less as compared with the previous year.
According to Mr Accuracy reports’s new survey, global Vector-Based RNAi market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Vector-Based RNAi market research.
Key manufacturers engaged in the Vector-Based RNAi industry include Merck & Co., Phio Pharmaceutical, Quark Pharmaceuticals, Thermo Fisher Scientific, Silence Therapeutics, Qiagen NV, Ionis Pharmaceutical, Dicerna Pharmaceuticals and Arrowhead Pharmaceuticals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Vector-Based RNAi were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Vector-Based RNAi market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vector-Based RNAi market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck & Co.
Phio Pharmaceutical
Quark Pharmaceuticals
Thermo Fisher Scientific
Silence Therapeutics
Qiagen NV
Ionis Pharmaceutical
Dicerna Pharmaceuticals
Arrowhead Pharmaceuticals
Arcturus Therapeutics
Alnylam Pharmaceuticals
Segment by Type
siRNA Design
siRNA Vectors
Custom siRNA Construction

Segment by Application


Hospitals
Speciality Clinics

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Vector-Based RNAi report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Vector-Based RNAi Market Overview
1.1 Product Overview and Scope of Vector-Based RNAi
1.2 Vector-Based RNAi Segment by Type
1.2.1 Global Vector-Based RNAi Market Value Comparison by Type (2024-2034)
1.2.2 siRNA Design
1.2.3 siRNA Vectors
1.2.4 Custom siRNA Construction
1.3 Vector-Based RNAi Segment by Application
1.3.1 Global Vector-Based RNAi Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.4 Global Vector-Based RNAi Market Size Estimates and Forecasts
1.4.1 Global Vector-Based RNAi Revenue 2018-2034
1.4.2 Global Vector-Based RNAi Sales 2018-2034
1.4.3 Global Vector-Based RNAi Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Vector-Based RNAi Market Competition by Manufacturers
2.1 Global Vector-Based RNAi Sales Market Share by Manufacturers (2018-2024)
2.2 Global Vector-Based RNAi Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Vector-Based RNAi Average Price by Manufacturers (2018-2024)
2.4 Global Vector-Based RNAi Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Vector-Based RNAi, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vector-Based RNAi, Product Type & Application
2.7 Vector-Based RNAi Market Competitive Situation and Trends
2.7.1 Vector-Based RNAi Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vector-Based RNAi Players Market Share by Revenue
2.7.3 Global Vector-Based RNAi Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vector-Based RNAi Retrospective Market Scenario by Region
3.1 Global Vector-Based RNAi Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Vector-Based RNAi Global Vector-Based RNAi Sales by Region: 2018-2034
3.2.1 Global Vector-Based RNAi Sales by Region: 2018-2024
3.2.2 Global Vector-Based RNAi Sales by Region: 2024-2034
3.3 Global Vector-Based RNAi Global Vector-Based RNAi Revenue by Region: 2018-2034
3.3.1 Global Vector-Based RNAi Revenue by Region: 2018-2024
3.3.2 Global Vector-Based RNAi Revenue by Region: 2024-2034
3.4 North America Vector-Based RNAi Market Facts & Figures by Country
3.4.1 North America Vector-Based RNAi Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Vector-Based RNAi Sales by Country (2018-2034)
3.4.3 North America Vector-Based RNAi Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vector-Based RNAi Market Facts & Figures by Country
3.5.1 Europe Vector-Based RNAi Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Vector-Based RNAi Sales by Country (2018-2034)
3.5.3 Europe Vector-Based RNAi Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vector-Based RNAi Market Facts & Figures by Country
3.6.1 Asia Pacific Vector-Based RNAi Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Vector-Based RNAi Sales by Country (2018-2034)
3.6.3 Asia Pacific Vector-Based RNAi Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Vector-Based RNAi Market Facts & Figures by Country
3.7.1 Latin America Vector-Based RNAi Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Vector-Based RNAi Sales by Country (2018-2034)
3.7.3 Latin America Vector-Based RNAi Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vector-Based RNAi Market Facts & Figures by Country
3.8.1 Middle East and Africa Vector-Based RNAi Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Vector-Based RNAi Sales by Country (2018-2034)
3.8.3 Middle East and Africa Vector-Based RNAi Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vector-Based RNAi Sales by Type (2018-2034)
4.1.1 Global Vector-Based RNAi Sales by Type (2018-2024)
4.1.2 Global Vector-Based RNAi Sales by Type (2024-2034)
4.1.3 Global Vector-Based RNAi Sales Market Share by Type (2018-2034)
4.2 Global Vector-Based RNAi Revenue by Type (2018-2034)
4.2.1 Global Vector-Based RNAi Revenue by Type (2018-2024)
4.2.2 Global Vector-Based RNAi Revenue by Type (2024-2034)
4.2.3 Global Vector-Based RNAi Revenue Market Share by Type (2018-2034)
4.3 Global Vector-Based RNAi Price by Type (2018-2034)
5 Segment by Application
5.1 Global Vector-Based RNAi Sales by Application (2018-2034)
5.1.1 Global Vector-Based RNAi Sales by Application (2018-2024)
5.1.2 Global Vector-Based RNAi Sales by Application (2024-2034)
5.1.3 Global Vector-Based RNAi Sales Market Share by Application (2018-2034)
5.2 Global Vector-Based RNAi Revenue by Application (2018-2034)
5.2.1 Global Vector-Based RNAi Revenue by Application (2018-2024)
5.2.2 Global Vector-Based RNAi Revenue by Application (2024-2034)
5.2.3 Global Vector-Based RNAi Revenue Market Share by Application (2018-2034)
5.3 Global Vector-Based RNAi Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Corporation Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Vector-Based RNAi Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck & Co. Vector-Based RNAi Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 Phio Pharmaceutical
6.2.1 Phio Pharmaceutical Corporation Information
6.2.2 Phio Pharmaceutical Description and Business Overview
6.2.3 Phio Pharmaceutical Vector-Based RNAi Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Phio Pharmaceutical Vector-Based RNAi Product Portfolio
6.2.5 Phio Pharmaceutical Recent Developments/Updates
6.3 Quark Pharmaceuticals
6.3.1 Quark Pharmaceuticals Corporation Information
6.3.2 Quark Pharmaceuticals Description and Business Overview
6.3.3 Quark Pharmaceuticals Vector-Based RNAi Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Quark Pharmaceuticals Vector-Based RNAi Product Portfolio
6.3.5 Quark Pharmaceuticals Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Vector-Based RNAi Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Thermo Fisher Scientific Vector-Based RNAi Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Silence Therapeutics
6.5.1 Silence Therapeutics Corporation Information
6.5.2 Silence Therapeutics Description and Business Overview
6.5.3 Silence Therapeutics Vector-Based RNAi Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Silence Therapeutics Vector-Based RNAi Product Portfolio
6.5.5 Silence Therapeutics Recent Developments/Updates
6.6 Qiagen NV
6.6.1 Qiagen NV Corporation Information
6.6.2 Qiagen NV Description and Business Overview
6.6.3 Qiagen NV Vector-Based RNAi Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Qiagen NV Vector-Based RNAi Product Portfolio
6.6.5 Qiagen NV Recent Developments/Updates
6.7 Ionis Pharmaceutical
6.6.1 Ionis Pharmaceutical Corporation Information
6.6.2 Ionis Pharmaceutical Description and Business Overview
6.6.3 Ionis Pharmaceutical Vector-Based RNAi Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Ionis Pharmaceutical Vector-Based RNAi Product Portfolio
6.7.5 Ionis Pharmaceutical Recent Developments/Updates
6.8 Dicerna Pharmaceuticals
6.8.1 Dicerna Pharmaceuticals Corporation Information
6.8.2 Dicerna Pharmaceuticals Description and Business Overview
6.8.3 Dicerna Pharmaceuticals Vector-Based RNAi Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Dicerna Pharmaceuticals Vector-Based RNAi Product Portfolio
6.8.5 Dicerna Pharmaceuticals Recent Developments/Updates
6.9 Arrowhead Pharmaceuticals
6.9.1 Arrowhead Pharmaceuticals Corporation Information
6.9.2 Arrowhead Pharmaceuticals Description and Business Overview
6.9.3 Arrowhead Pharmaceuticals Vector-Based RNAi Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Arrowhead Pharmaceuticals Vector-Based RNAi Product Portfolio
6.9.5 Arrowhead Pharmaceuticals Recent Developments/Updates
6.10 Arcturus Therapeutics
6.10.1 Arcturus Therapeutics Corporation Information
6.10.2 Arcturus Therapeutics Description and Business Overview
6.10.3 Arcturus Therapeutics Vector-Based RNAi Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Arcturus Therapeutics Vector-Based RNAi Product Portfolio
6.10.5 Arcturus Therapeutics Recent Developments/Updates
6.11 Alnylam Pharmaceuticals
6.11.1 Alnylam Pharmaceuticals Corporation Information
6.11.2 Alnylam Pharmaceuticals Vector-Based RNAi Description and Business Overview
6.11.3 Alnylam Pharmaceuticals Vector-Based RNAi Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Alnylam Pharmaceuticals Vector-Based RNAi Product Portfolio
6.11.5 Alnylam Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vector-Based RNAi Industry Chain Analysis
7.2 Vector-Based RNAi Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vector-Based RNAi Production Mode & Process
7.4 Vector-Based RNAi Sales and Marketing
7.4.1 Vector-Based RNAi Sales Channels
7.4.2 Vector-Based RNAi Distributors
7.5 Vector-Based RNAi Customers
8 Vector-Based RNAi Market Dynamics
8.1 Vector-Based RNAi Industry Trends
8.2 Vector-Based RNAi Market Drivers
8.3 Vector-Based RNAi Market Challenges
8.4 Vector-Based RNAi Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Vector-Based RNAi Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Vector-Based RNAi Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Vector-Based RNAi Market Competitive Situation by Manufacturers in 2022
Table 4. Global Vector-Based RNAi Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Vector-Based RNAi Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Vector-Based RNAi Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Vector-Based RNAi Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Vector-Based RNAi Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Vector-Based RNAi, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Vector-Based RNAi, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vector-Based RNAi, Product Type & Application
Table 12. Global Key Manufacturers of Vector-Based RNAi, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vector-Based RNAi by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vector-Based RNAi as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vector-Based RNAi Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Vector-Based RNAi Sales by Region (2018-2024) & (K Units)
Table 18. Global Vector-Based RNAi Sales Market Share by Region (2018-2024)
Table 19. Global Vector-Based RNAi Sales by Region (2024-2034) & (K Units)
Table 20. Global Vector-Based RNAi Sales Market Share by Region (2024-2034)
Table 21. Global Vector-Based RNAi Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Vector-Based RNAi Revenue Market Share by Region (2018-2024)
Table 23. Global Vector-Based RNAi Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Vector-Based RNAi Revenue Market Share by Region (2024-2034)
Table 25. North America Vector-Based RNAi Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Vector-Based RNAi Sales by Country (2018-2024) & (K Units)
Table 27. North America Vector-Based RNAi Sales by Country (2024-2034) & (K Units)
Table 28. North America Vector-Based RNAi Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Vector-Based RNAi Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Vector-Based RNAi Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Vector-Based RNAi Sales by Country (2018-2024) & (K Units)
Table 32. Europe Vector-Based RNAi Sales by Country (2024-2034) & (K Units)
Table 33. Europe Vector-Based RNAi Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Vector-Based RNAi Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Vector-Based RNAi Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Vector-Based RNAi Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Vector-Based RNAi Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Vector-Based RNAi Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Vector-Based RNAi Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Vector-Based RNAi Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Vector-Based RNAi Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Vector-Based RNAi Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Vector-Based RNAi Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Vector-Based RNAi Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Vector-Based RNAi Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Vector-Based RNAi Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Vector-Based RNAi Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Vector-Based RNAi Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Vector-Based RNAi Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Vector-Based RNAi Sales (K Units) by Type (2018-2024)
Table 51. Global Vector-Based RNAi Sales (K Units) by Type (2024-2034)
Table 52. Global Vector-Based RNAi Sales Market Share by Type (2018-2024)
Table 53. Global Vector-Based RNAi Sales Market Share by Type (2024-2034)
Table 54. Global Vector-Based RNAi Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Vector-Based RNAi Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Vector-Based RNAi Revenue Market Share by Type (2018-2024)
Table 57. Global Vector-Based RNAi Revenue Market Share by Type (2024-2034)
Table 58. Global Vector-Based RNAi Price (US$/Unit) by Type (2018-2024)
Table 59. Global Vector-Based RNAi Price (US$/Unit) by Type (2024-2034)
Table 60. Global Vector-Based RNAi Sales (K Units) by Application (2018-2024)
Table 61. Global Vector-Based RNAi Sales (K Units) by Application (2024-2034)
Table 62. Global Vector-Based RNAi Sales Market Share by Application (2018-2024)
Table 63. Global Vector-Based RNAi Sales Market Share by Application (2024-2034)
Table 64. Global Vector-Based RNAi Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Vector-Based RNAi Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Vector-Based RNAi Revenue Market Share by Application (2018-2024)
Table 67. Global Vector-Based RNAi Revenue Market Share by Application (2024-2034)
Table 68. Global Vector-Based RNAi Price (US$/Unit) by Application (2018-2024)
Table 69. Global Vector-Based RNAi Price (US$/Unit) by Application (2024-2034)
Table 70. Merck & Co. Corporation Information
Table 71. Merck & Co. Description and Business Overview
Table 72. Merck & Co. Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Merck & Co. Vector-Based RNAi Product
Table 74. Merck & Co. Recent Developments/Updates
Table 75. Phio Pharmaceutical Corporation Information
Table 76. Phio Pharmaceutical Description and Business Overview
Table 77. Phio Pharmaceutical Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Phio Pharmaceutical Vector-Based RNAi Product
Table 79. Phio Pharmaceutical Recent Developments/Updates
Table 80. Quark Pharmaceuticals Corporation Information
Table 81. Quark Pharmaceuticals Description and Business Overview
Table 82. Quark Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Quark Pharmaceuticals Vector-Based RNAi Product
Table 84. Quark Pharmaceuticals Recent Developments/Updates
Table 85. Thermo Fisher Scientific Corporation Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Thermo Fisher Scientific Vector-Based RNAi Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Silence Therapeutics Corporation Information
Table 91. Silence Therapeutics Description and Business Overview
Table 92. Silence Therapeutics Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Silence Therapeutics Vector-Based RNAi Product
Table 94. Silence Therapeutics Recent Developments/Updates
Table 95. Qiagen NV Corporation Information
Table 96. Qiagen NV Description and Business Overview
Table 97. Qiagen NV Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Qiagen NV Vector-Based RNAi Product
Table 99. Qiagen NV Recent Developments/Updates
Table 100. Ionis Pharmaceutical Corporation Information
Table 101. Ionis Pharmaceutical Description and Business Overview
Table 102. Ionis Pharmaceutical Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Ionis Pharmaceutical Vector-Based RNAi Product
Table 104. Ionis Pharmaceutical Recent Developments/Updates
Table 105. Dicerna Pharmaceuticals Corporation Information
Table 106. Dicerna Pharmaceuticals Description and Business Overview
Table 107. Dicerna Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Dicerna Pharmaceuticals Vector-Based RNAi Product
Table 109. Dicerna Pharmaceuticals Recent Developments/Updates
Table 110. Arrowhead Pharmaceuticals Corporation Information
Table 111. Arrowhead Pharmaceuticals Description and Business Overview
Table 112. Arrowhead Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Arrowhead Pharmaceuticals Vector-Based RNAi Product
Table 114. Arrowhead Pharmaceuticals Recent Developments/Updates
Table 115. Arcturus Therapeutics Corporation Information
Table 116. Arcturus Therapeutics Description and Business Overview
Table 117. Arcturus Therapeutics Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Arcturus Therapeutics Vector-Based RNAi Product
Table 119. Arcturus Therapeutics Recent Developments/Updates
Table 120. Alnylam Pharmaceuticals Corporation Information
Table 121. Alnylam Pharmaceuticals Description and Business Overview
Table 122. Alnylam Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Alnylam Pharmaceuticals Vector-Based RNAi Product
Table 124. Alnylam Pharmaceuticals Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Vector-Based RNAi Distributors List
Table 128. Vector-Based RNAi Customers List
Table 129. Vector-Based RNAi Market Trends
Table 130. Vector-Based RNAi Market Drivers
Table 131. Vector-Based RNAi Market Challenges
Table 132. Vector-Based RNAi Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vector-Based RNAi
Figure 2. Global Vector-Based RNAi Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Vector-Based RNAi Market Share by Type in 2022 & 2034
Figure 4. siRNA Design Product Picture
Figure 5. siRNA Vectors Product Picture
Figure 6. Custom siRNA Construction Product Picture
Figure 7. Global Vector-Based RNAi Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Vector-Based RNAi Market Share by Application in 2022 & 2034
Figure 9. Hospitals
Figure 10. Speciality Clinics
Figure 11. Global Vector-Based RNAi Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Vector-Based RNAi Market Size (2018-2034) & (US$ Million)
Figure 13. Global Vector-Based RNAi Sales (2018-2034) & (K Units)
Figure 14. Global Vector-Based RNAi Average Price (US$/Unit) & (2018-2034)
Figure 15. Vector-Based RNAi Report Years Considered
Figure 16. Vector-Based RNAi Sales Share by Manufacturers in 2022
Figure 17. Global Vector-Based RNAi Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Vector-Based RNAi Players: Market Share by Revenue in 2022
Figure 19. Vector-Based RNAi Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Vector-Based RNAi Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 21. North America Vector-Based RNAi Sales Market Share by Country (2018-2034)
Figure 22. North America Vector-Based RNAi Revenue Market Share by Country (2018-2034)
Figure 23. United States Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Vector-Based RNAi Sales Market Share by Country (2018-2034)
Figure 26. Europe Vector-Based RNAi Revenue Market Share by Country (2018-2034)
Figure 27. Germany Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Vector-Based RNAi Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Vector-Based RNAi Revenue Market Share by Region (2018-2034)
Figure 34. China Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Vector-Based RNAi Sales Market Share by Country (2018-2034)
Figure 44. Latin America Vector-Based RNAi Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Vector-Based RNAi Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Vector-Based RNAi Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Vector-Based RNAi Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Vector-Based RNAi by Type (2018-2034)
Figure 54. Global Revenue Market Share of Vector-Based RNAi by Type (2018-2034)
Figure 55. Global Vector-Based RNAi Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Vector-Based RNAi by Application (2018-2034)
Figure 57. Global Revenue Market Share of Vector-Based RNAi by Application (2018-2034)
Figure 58. Global Vector-Based RNAi Price (US$/Unit) by Application (2018-2034)
Figure 59. Vector-Based RNAi Value Chain
Figure 60. Vector-Based RNAi Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries